/

Other

/

Xellia Pharmaceuticals

Xellia Pharmaceuticals

Xellia Pharmaceuticals

Verified Nov 2026

Other

·

Copenhagen, Capital Region of Denmark

·

Since 1903

Xellia Pharmaceuticals, headquartered in Copenhagen and founded in 1903, is a specialty pharmaceutical manufacturer with 1,000–5,000 employees. The company produces fermentation-based non-beta-lactam anti-infectives, active pharmaceutical ingredients, and injectable formulations, serving medical, healthcare, and critical-care sectors. In March 2026, Xellia acquired an industrial facility in Hungary to expand manufacturing capacity.

Xellia Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

1903

Headquarters

Copenhagen, Capital Region of Denmark

Employees

1,000-5,000

Ownership

Xellia Pharmaceuticals at a glance

Revenue

$100-250M

Est. band

Employees

1,000-5,000

Founded

1903

Headquarters

Copenhagen, Capital Region of Denmark

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Overview

Xellia Pharmaceuticals, headquartered in Copenhagen and founded in 1903, is a specialty pharmaceutical manufacturer with 1,000–5,000 employees. The company produces fermentation-based non-beta-lactam anti-infectives, active pharmaceutical ingredients, and injectable formulations, serving medical, healthcare, and critical-care sectors. In March 2026, Xellia acquired an industrial facility in Hungary to expand manufacturing capacity.

At a glance

Attribute

Detail

Founded

1903

Headquarters

Copenhagen, Capital Region of Denmark

Employees

1,000-5,000

Revenue

$100-250M (estimated)

What Xellia Pharmaceuticals makes

Xellia manufactures fermentation-based active pharmaceutical ingredients including vancomycin and colistimethate sodium, and provides contract manufacturing and finished injectable dosage forms for hospital use.

Latest developments

Facilities

Xellia Pharmaceuticals is headquartered in Copenhagen, Capital Region of Denmark. Public sources also reference these locations:

Company details

Xellia is owned by Novo Holdings and employs approximately 1,800 people across its global operations. Xellia Pharmaceuticals was founded in 1903, has an estimated 1,000-5,000 employees, and is headquartered in Copenhagen, Capital Region of Denmark.

Frequently asked questions

What does Xellia Pharmaceuticals do?

Xellia Pharmaceuticals, headquartered in Copenhagen and founded in 1903, is a specialty pharmaceutical manufacturer with 1,000–5,000 employees. The company produces fermentation-based non-beta-lactam anti-infectives, active pharmaceutical ingredients, and injectable formulations, serving medical, healthcare, and critical-care sectors. In March 2026, Xellia acquired an industrial facility in Hungary to expand manufacturing capacity.

Where is Xellia Pharmaceuticals headquartered?

Xellia Pharmaceuticals is headquartered in Copenhagen, Capital Region of Denmark (11 Dalslandsgade, Copenhagen, Capital Region of Denmark, 2300).

When was Xellia Pharmaceuticals founded?

Xellia Pharmaceuticals was founded in 1903.

How big is Xellia Pharmaceuticals?

Xellia Pharmaceuticals has an estimated 1,000-5,000 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Copenhagen, Capital Region of Denmark (HQ)Headquarters · Denmark
Copenhagen, Capital Region of Denmark (HQ)11 Dalslandsgade, Copenhagen, Capital Region of Denmark, 2300, DenmarkHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.